Characterization of tumor relevant isocitrate dehydrogenase 1 (IDH1)

被引:0
|
作者
Coleman, Nalani J. [1 ]
Thornberg, Ella [1 ]
Caliger, Danielle [1 ]
Luna, Lucas [1 ]
Sohl, Christal D. [1 ]
机构
[1] San Diego State Univ, San Diego, CA 92182 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1158/1538-7445.AM2020-3732
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3732
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Isocitrate Dehydrogenase 1 (IDH1) Mutations in Melanoma Frequently Co-Occur with NRAS Mutations
    Linos, Konstantinos
    Peterson, Jason D.
    Deharvengt, Sophie J.
    de Abreu, Francine B.
    Shirai, Keisuke
    Tsongalis, Gregory J.
    Tafe, Laura
    MODERN PATHOLOGY, 2017, 30 : 133A - 133A
  • [32] Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation Is Not Detected in Angiocentric Glioma
    Raghunathan, A.
    Olar, A.
    Vogel, H.
    Parker, J. R.
    Coventry, S. C.
    Debski, R.
    Albarracin, C. T.
    Aldape, K. D.
    Cahill, D. P.
    Powell, S. Z.
    Fuller, G. N.
    LABORATORY INVESTIGATION, 2011, 91 : 384A - 384A
  • [33] Radioiodinated AGI-5198 for in vivo imaging of isocitrate dehydrogenase 1 (IDH1) mutation in gliomas
    Chitneni, Satish
    Reitman, Zachary
    Yan, Hai
    Zalutsky, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [34] R132 mutations in canine isocitrate dehydrogenase 1 (IDH1) lead to functional changes
    Shota Kawakami
    Kazuhiko Ochiai
    Daigo Azakami
    Yuiko Kato
    Masaki Michishita
    Masami Morimatsu
    Toshina Ishiguro-Oonuma
    Eri Onozawa
    Masami Watanabe
    Toshinori Omi
    Veterinary Research Communications, 2018, 42 : 49 - 56
  • [35] Textiloma resembling anaplastic progression of an isocitrate dehydrogenase 1 (IDH1) mutant, low grade glioma
    Anderson, Mark Daniel
    Raghunathan, Aditya
    Gilbert, Mark R.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (03) : 377 - 379
  • [36] Non-Small Cell Lung Cancer with Isocitrate Dehydrogenase (IDH1/IDH2) Mutations
    Toth, L. N.
    Peterson, J. D.
    de Abreu, F.
    Tsongalis, G. J.
    Tafe, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1029 - 1029
  • [37] Variation in the kinetic parameters and structural features of tumor-driving isocitrate dehydrogenase 1 (IDH1) mutants tune phenotype severity
    Sohl, Christal
    Mealka, Matthew
    Sabo, Kaitlyn
    Albekioni, Elene
    Adam, Mowaffaq
    Silletti, Steve
    Robinson, Mikella
    House, Carrie
    Huxford, Tom
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S296 - S296
  • [38] Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1)
    Brooks, Nathan
    DeWalt, Robin
    Boulet, Serge
    Lu, ZhaoHai
    Kays, Lisa
    Cavitt, Rachel
    Gomez, Sandra
    Strelow, John
    Milligan, Paul
    Roth, Kenneth
    Bauer, Renato
    Antonysamy, Stephen
    Hahn, Patric
    Rankovic, Zoran
    McCann, Denis
    Mo, Gary
    Tiu, Ramon
    Burkholder, Timothy
    Geeganage, Sandaruwan
    Gilmour, Raymond
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Mutant IDH1 is required for IDH1 mutated tumor cell growth
    Jin, Genglin
    Pirozzi, Christopher J.
    Chen, Lee H.
    Lopez, Giselle Y.
    Duncan, Christopher G.
    Feng, Jie
    Spasojevic, Ivan
    Bigner, Darell D.
    He, Yiping
    Yan, Hai
    ONCOTARGET, 2012, 3 (08) : 774 - 782
  • [40] Isocitrate Dehydrogenase 1 and 2 (IDH1 and IDH2) Mutations in Solid Organ Malignancies by Next-Generation Sequencing
    Roy-Chowdhuri, S.
    Goswami, R. S.
    Chen, H.
    Routbort, M. J.
    Patel, K. P.
    Aldape, K.
    Lazar, A. J.
    Broaddus, R.
    Singh, R. R.
    Luthra, R.
    Kanagal-Shamanna, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 767 - 767